US FDA May Reconsider RMAT Requests If Resubmitted With Sufficient Clinical Data

 
• By Joanne S. Eglovitch
  
PS2007_Fat Lipolytics_1766034437_1200.jpg
Cell Therapy Product Uses Healthy Thigh Muscle Cells To Treat Urinary Incontinence • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D